Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription and reexpression of a protective fetal program

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 3, 2008, Pages 709-716

  Bovill, Esta ^a   Westaby, Stephen ^b   Reji, Shiney ^a   Sayeed, Rana ^b   Crisp, Alastair ^c   Shaw, Tony ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN LIGHT CHAIN 2; PROTEIN JARID2; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; AORTA VALVE STENOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; AORTIC VALVE STENOSIS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CARDIAC MYOSINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MICE; MIDDLE AGED; MYOSIN LIGHT CHAINS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, MECHANICAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VENTRICULAR MYOSINS;

EID: 52049126813     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.02.020     Document Type: Article

References (41)

1. Katz A.M. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses. J Cell Mol Med 7 (2003) 1-10
2. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999) 215-262
3. Chien K.R., Knowlton K.U., Zhu H., and Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5 (1991) 3037-3046
4. Vesely D.L. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 51 (2001) 647-658
5. Drexler H., Hanze J., Finckh M., Lu W., Just H., and Lang R.E. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation 79 (1989) 620-633
6. Sugawara A., Nakao K., Morii N., Yamada T., Itoh H., Shiono S., et al. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. J Clin Invest 81 (1988) 1962-1970
7. Tsuchimochi H., Kurimoto F., Ieki K., Koyama H., Takaku F., Kawana M., et al. Atrial natriuretic peptide distribution in fetal and failed adult human hearts. Circulation 78 (1988) 920-927
8. Nakao K., Minobe W., Roden R., Bristow M.R., and Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest 100 (1997) 2362-2370
9. Lowes B.D., Minobe W., Abraham W.T., Rizeq M.N., Bohlmeyer T.J., Quaife R.A., et al. Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100 (1997) 2315-2324
10. Walsh R., Henkel R., and Robbins J. Cardiac myosin heavy- and light-chain gene expression in hypertrophy and heart disease. Heart Failure 6 (1991) 238-243
11. Morin S., Charron F., Robitaille L., and Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J 19 (2000) 2046-2055
12. Durocher D., Chen C.Y., Ardati A., Schwartz R.J., and Nemer M. The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol 16 (1996) 4648-4655
13. Fattaey A.R., Helin K., Dembski M.S., Dyson N., Harlow E., Vuocolo G.A., et al. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 8 (1993) 3149-3156
14. Gregory S.L., Kortschak R.D., Kalionis B., and Saint R. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol Cell Biol 16 (1996) 792-799
15. Peterson C.L., and Herskowitz I. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell 68 (1992) 573-583
16. Kim T.G., Chen J., Sadoshima J., and Lee Y. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol Cell Biol 24 (2004) 10151-10160
17. Kim T.G., Kraus J.C., Chen J., and Lee Y. JUMONJI, a critical factor for cardiac development, functions as a transcriptional repressor. J Biol Chem 278 (2003) 42247-42255
18. Kim T.G., Jung J., Mysliwiec M.R., Kang S., and Lee Y. Jumonji represses α-cardiac myosin heavy chain expression via inhibiting MEF2 activity. Biochem Biophys Res Commun 329 (2005) 544-553
19. Toyoda M., Shirato H., Nakajima K., Kojima M., Takahashi M., Kubota M., et al. jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 5 (2003) 85-97
20. Ohno T., Nakajima K., Kojima M., Toyoda M., and Takeuchi T. Modifiers of the jumonji mutation downregulate cyclin D1 expression and cardiac cell proliferation. Biochem Biophys Res Commun 317 (2004) 925-929
21. Takahashi M., Kojima M., Nakajima K., Suzuki-Migishima R., and Takeuchi T. Functions of a jumonji-cyclin D1 pathway in the coordination of cell cycle exit and migration during neurogenesis in the mouse hindbrain. Dev Biol 303 (2007) 549-560
22. Lee Y., Song A.J., Baker R., Micales B., Conway S.J., and Lyons G.E. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 86 (2000) 932-938
23. Takeuchi T., Kojima M., Nakajima K., and Kondo S. jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech Dev 86 (1999) 29-38
24. Argentin S., Ardati A., Tremblay S., Lihrmann I., Robitaille L., Drouin J., et al. Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol Cell Biol 14 (1994) 777-790
25. Lyons G.E. In situ analysis of the cardiac muscle gene program during embryogenesis. Trends Cardiovasc Med 4 (1994) 70-77
26. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
27. Kemp T.J., Sadusky T.J., Simon M., Brown R., Eastwood M., Sassoon D.A., et al. Identification of a novel stretch-responsive skeletal muscle gene (Smpx). Genomics 72 (2001) 260-271
28. Doevendans P.A., Bronsaer R., Lozano P.R., Kubalak S., and van Bilsen M. The murine atrial myosin light chain-2 gene: a member of an evolutionarily conserved family of contractile proteins. Cytogenet Cell Genet 90 (2000) 248-252
29. Gulick J., Hewett T.E., Klevitsky R., Buck S.H., Moss R.L., and Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res 80 (1997) 655-664
30. Wu W.S., Vallian S., Seto E., Yang W.M., Edmondson D., Roth S., et al. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol 21 (2001) 2259-2268
31. Claycomb W.C., Lanson Jr. N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95 (1998) 2979-2984
32. Shroff S.G., and Motz W. Left ventricular systolic resistance in rats with hypertension and hypertrophy. Am J Physiol 257 2 Pt 2 (1989) H386-H394
33. Shroff S.G., Naegelen D., and Clark W.A. Relation between left ventricular systolic resistance and contractile rate processes. Am J Physiol 258 2 Pt 2 (1990) H381-H394
34. Miyata S., Minobe W., Bristow M.R., and Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86 (2000) 386-390
35. Molkentin J.D., Kalvakolanu D.V., and Markham B.E. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the α-myosin heavy-chain gene. Mol Cell Biol 14 (1994) 4947-4957
36. Kubalak S.W., Miller-Hance W.C., O'Brien T.X., Dyson E., and Chien K.R. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem 269 (1994) 16961-16970
37. Chen J., Kubalak S.W., Minamisawa S., Price R.L., Becker K.D., Hickey R., et al. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem 273 (1998) 1252-1256
38. Small E.M., and Krieg P.A. Molecular regulation of cardiac chamber-specific gene expression. Trends Cardiovasc Med 14 (2004) 13-18
39. Zeller R., Bloch K.D., Williams B.S., Arceci R.J., and Seidman C.E. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev 1 (1987) 693-698
40. Knowlton K.U., Rockman H.A., Itani M., Vovan A., Seidman C.E., and Chien K.R. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest 96 (1995) 1311-1318
41. Takimoto E., Mizuno T., Terasaki F., Shimoyama M., Honda H., Shiojima I., et al. Up-regulation of natriuretic peptides in the ventricle of Csx/Nkx2-5 transgenic mice. Biochem Biophys Res Commun 270 (2000) 1074-1079